Pure Global

IVD Department quantitative procalcitonin testing - Vietnam Registration 2403763ĐKLH/BYT-HTTB

Access comprehensive regulatory information for IVD Department quantitative procalcitonin testing in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2403763ĐKLH/BYT-HTTB. The authorized representative in Vietnam is VĂN PHÒNG ĐẠI DIỆN LIFE TECHNOLOGIES HOLDINGS PTE. LTD. TẠI THÀNH PHỐ HỒ CHÍ MINH.

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Ortho-Clinical Diagnostics, and 1 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
1 Competitors
1 Recent Registrations
2403763ĐKLH/BYT-HTTB
Registration Details
Vietnam MOH Registration: 2403763ĐKLH/BYT-HTTB
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

IVD Department quantitative procalcitonin testing
VN: Bộ IVD xét nghiệm định lượng procalcitonin
Risk Class TTBYT Loại C

Registration Details

2403763ĐKLH/BYT-HTTB

20011547/ĐKLH-BYT-TB-CT

Theo theo phụ lục

Theo phụ lục

Technical Details

*) Drug test for quantitative procalcitonin (B·R·A·H·M·S PCT sensitive KRYPTOR): The B·R·A·H·M·S PCT sensitive KRYPTOR test is an automated fluorescent immunoassay to determine the quantitative concentration of procalcitonin (PCT) in human serum or plasma (EDTA, heparin). PCT is a host response marker for bacterial infection. The B·R·A·H·M·S PCT sensitive KRYPTOR test is indicated as a support to be used in combination with clinical assessment to: •detect and differentiate clinically relevant infections, •assess the severity and prognosis of systemic, sepsis, severe sepsis and septic shock, •determine patients who benefit from antibiotic therapy, •monitor antibiotic therapy within the range of the test, •assess the success of antibiotic therapy in patients suspected or confirmed to have a bacterial infection. Note: The results of the B·R·A·H·M·S PCT sensitive KRYPTOR test must always be interpreted in the context of all the patient's test results and clinical assessment. *) Calibration standard for quantitative procalcitonin test (B·R·A·H·M·S PCT sensitive KRYPTOR CAL): to calibrate the stored calibration standard of the B·R·A·H·M·S KRYPTOR/ KRYPTOR compact/ KRYPTOR compact PLUS/ KRYPTOR GOLD instrument. *) Quality control material for quantitative procalcitonin test (B·R·A·H·M·S PCT sensitive KRYPTOR QC): quality control material for the B·R·A·H·M·S KRYPTOR/ KRYPTOR compact/ KRYPTOR compact PLUS/ KRYPTOR GOLD instrument.

Dates and Status

Nov 19, 2024

Companies Making Similar Products
Companies providing products similar to "IVD Department quantitative procalcitonin testing"